Personalized Medicine And AI Will Redefine Diagnostics
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 20 Analysts
Published
21 Aug 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
US$255.00
36.3% undervalued intrinsic discount21 Aug
US$162.47
1Y
37.6%7D
0.8%1Y
37.6%7D
0.8%